Natural relief of menopausal symptoms.
Promensil is rapidly becoming the product of choice for both women approaching menopause and those who are currently experiencing it.
The incidence of acute menopausal symptoms and long-term post-menopausal disorders (osteoporosis and cardiovascular disease) is far greater in women in North America, Canada, Australia, New Zealand, and Western Europe compared to women in Asian, Central American and Mediterranean countries. Scientific research has found that the reason for this is due to differences in diet, and specifically in the low intake of isoflavone phytoestrogens in the Western diet.
Falling estrogen levels during menopause bring physical changes requiring lifestyle adjustments that can be debilitating for some women. With increasing age and declining estrogen production, isoflavones become increasingly important, taking over the role of the body's estrogen.
This is where the unique combination of isoflavones in Promensil is intended to help. Promensil assists women by the supplementation of isoflavones to help manage the symptoms of menopause naturally. Promensil tablets are derived from red clover, a legume which contains 40mg of the four isoflavones beneficial to human health. Acting as a dietary supplement, Promensil provides you with natural isoflavones which are effective in relieving symptoms of menopause, such as hot flushes, as well as maintaining wellbeing and quality of life. This means that you donthave to modify your diet to include large amounts of legumes.
Promensil is available in 30-tablet (one month) blister pack, with a daily calendar indicator.
What else should I know?
Red clover (Trifolium pratense) isoflavones 40mg equiv to dry herb 13.3g.
Take One tablet daily with a meal.
Most women will notice an improvement in symptoms within 3 to 8 weeks.
NOTE: Customer reviews are written by website visitors and are not intended as medical advice.
Average Customer Review: Not yet rated
Write an online review and share your thoughts with others.
blog & more!
Click here to read